Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical models for the anemia of inflammation.

Literature DB >> 24558192

Critical models for the anemia of inflammation.

Paula G Fraenkel¹.
1. HARVARD MEDICAL SCHOOL.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 24558192 PMCID： PMC3931186 DOI： 10.1182/blood-2014-01-546994

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

× No keyword cloud information.

11 in total

Review 1. Hepcidin and iron homeostasis.

Authors: Tomas Ganz; Elizabeta Nemeth
Journal: Biochim Biophys Acta Date: 2012-01-26

2. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.

Authors: Soken-Nakazawa J Song; Naohisa Tomosugi; Hiroshi Kawabata; Takayuki Ishikawa; Teppei Nishikawa; Kazuyuki Yoshizaki
Journal: Blood Date: 2010-07-19 Impact factor: 22.113

3. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.

Authors: Sara Gardenghi; Tom M Renaud; Alessandra Meloni; Carla Casu; Bart J Crielaard; Laura M Bystrom; Noa Greenberg-Kushnir; Barbra J Sasu; Keegan S Cooke; Stefano Rivella
Journal: Blood Date: 2013-12-19 Impact factor: 22.113

4. Interleukin-6 induces hepcidin expression through STAT3.

Authors: Diedra M Wrighting; Nancy C Andrews
Journal: Blood Date: 2006-07-11 Impact factor: 22.113

5. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.

Authors: C E van Iperen; C A Gaillard; R J Kraaijenhagen; B G Braam; J J Marx; A van de Wiel
Journal: Crit Care Med Date: 2000-08 Impact factor: 7.598

6. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.

Authors: Barbra J Sasu; Keegan S Cooke; Tara L Arvedson; Cherylene Plewa; Aaron R Ellison; Jackie Sheng; Aaron Winters; Todd Juan; Hongyan Li; C Glenn Begley; Graham Molineux
Journal: Blood Date: 2010-01-06 Impact factor: 22.113

Critical models for the anemia of inflammation.

Review 1. Hepcidin and iron homeostasis.

2. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.

3. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.

4. Interleukin-6 induces hepcidin expression through STAT3.

5. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.

6. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.

Review 7. Animal models of anemia of inflammation.

8. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

9. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

10. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin.

1. TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.

2. Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation.